Eloxx Pharmaceuticals, Inc. Tangible Net Worth Ratio
Eloxx Pharmaceuticals, Inc. tangible net worth ratio. Eloxx Pharmaceuticals, Inc. (ELOX) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($46.42 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Eloxx Pharmaceuticals, Inc. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Eloxx Pharmaceuticals, Inc. (2004–2021)
Tangible net worth ratio of Eloxx Pharmaceuticals, Inc. from 2004 to 2021. This chart shows how Eloxx Pharmaceuticals, Inc.'s Tangible Net Worth Ratio has changed across 18 annual periods from 2004 to 2021. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $46.42 Million with intangible assets of $0.00 USD.
Eloxx Pharmaceuticals, Inc. Tangible Net Worth Ratio by Year (2004–2021)
Eloxx Pharmaceuticals, Inc. tangible net worth ratio by year from 2004 to 2021. The table below presents the year-by-year Tangible Net Worth Ratio for Eloxx Pharmaceuticals, Inc. from 2004 to 2021, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ELOX market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $22.38 Million | $0.00 | $45.14 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $10.23 Million | $0.00 | $26.48 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $36.21 Million | $0.00 | $58.95 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $42.91 Million | $0.00 | $50.72 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $21.36 Million | $0.00 | $24.78 Million | ▲ +177.6 pp |
| 2016 | -77.6% | $4.56 Million | $8.10 Million | $9.23 Million | ▼ -97.4 pp |
| 2015 | 19.8% | $12.22 Million | $9.80 Million | $19.55 Million | ▼ -36.6 pp |
| 2014 | 56.4% | $27.49 Million | $11.98 Million | $33.33 Million | ▼ -43.6 pp |
| 2013 | 100.0% | $3.89 Million | $0.00 | $7.10 Million | ▲ +95.5 pp |
| 2012 | 4.5% | $3.55 Million | $3.39 Million | $6.95 Million | ▼ -17.5 pp |
| 2011 | 22.0% | $4.52 Million | $3.52 Million | $8.60 Million | ▼ -78.0 pp |
| 2010 | 100.0% | $7.98 Million | $0.00 | $13.91 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $5.67 Million | $0.00 | $7.12 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $9.84 Million | $0.00 | $10.64 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $2.69 Million | $0.00 | $3.32 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $2.95 Million | $0.00 | $3.54 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $5.59 Million | $0.00 | $6.11 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $4.73 Million | $0.00 | $5.21 Million | — |